Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents - PubMed (original) (raw)
Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents
Y Pommier et al. Biochemistry. 1984.
Abstract
The biochemical characteristics of the formation and disappearance of intercalator-induced DNA double-strand breaks (DSB) were studied in nuclei from mouse leukemia L1210 cells by using filter elution methodology [Bradley, M. O., & Kohn, K.W. (1979) Nucleic Acids Res. 7, 793-804]. The three intercalators used were 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA), 5-iminodaunorubicin (5-ID), and ellipticine. These compounds differ in that they produced predominantly DNA single-strand breaks (SSB) (m-AMSA) or predominantly DNA double-strand breaks (ellipticine) or a mixture of both SSB and DSB (5-ID) in whole cells. In isolated nuclei, each intercalator produced DSB at a frequency comparable to that which is produced in whole cells. Moreover, these DNA breaks reversed within 30 min after drug removal. It thus appeared that neither ATP nor other nucleotides were necessary for intercalator-dependent DNA nicking-closing reactions. The formation of the intercalator-induced DSB was reduced at ice temperature. Break formation was also reduced in the absence of magnesium, at a pH above 6.4 and at NaCl concentrations above 200 mM. In the presence of ATP and ATP analogues, the intercalator-induced cleavage was enhanced. These results suggest that the intercalator-induced DSB are enzymatically mediated and that the enzymes involved in these reactions can catalyze DNA double-strand cleavage and rejoining in the absence of ATP, although the occupancy of an ATP binding site might convert the enzyme to a form more reactive to intercalators. Three inhibitors of DNA topoisomerase II--novobiocin, nalidixic acid, and norfloxacin--reduced the formation of DNA strand breaks.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
Zwelling LA, Michaels S, Erickson LC, Ungerleider RS, Nichols M, Kohn KW. Zwelling LA, et al. Biochemistry. 1981 Nov 10;20(23):6553-63. doi: 10.1021/bi00526a006. Biochemistry. 1981. PMID: 6895473 - Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei.
Pommier Y, Schwartz RE, Zwelling LA, Kohn KW. Pommier Y, et al. Biochemistry. 1985 Nov 5;24(23):6406-10. doi: 10.1021/bi00344a014. Biochemistry. 1985. PMID: 3002439 - Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites.
Zwelling LA, Silberman L, Estey E. Zwelling LA, et al. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1041-7. doi: 10.1016/0360-3016(86)90222-1. Int J Radiat Oncol Biol Phys. 1986. PMID: 2427489 Review. - DNA topoisomerase II as a target of antineoplastic drug therapy.
Zwelling LA. Zwelling LA. Cancer Metastasis Rev. 1985;4(4):263-76. doi: 10.1007/BF00048092. Cancer Metastasis Rev. 1985. PMID: 3000574 Review.
Cited by
- Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells. Comparison with its parent drug, doxorubicin.
Cantoni O, Sestili P, Cattabeni F, Geroni C, Grandi M, Giuliani FC. Cantoni O, et al. J Cancer Res Clin Oncol. 1989;115(4):373-8. doi: 10.1007/BF00400965. J Cancer Res Clin Oncol. 1989. PMID: 2760101 - Topoisomerase inhibitors suppressed lithocholic acid-induced promotion of transformation in BALB/3T3.
Kaneko M, Horikoshi J. Kaneko M, et al. Br J Cancer. 1987 Nov;56(5):614-6. doi: 10.1038/bjc.1987.251. Br J Cancer. 1987. PMID: 2827718 Free PMC article. No abstract available. - DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
Pommier Y, Leo E, Zhang H, Marchand C. Pommier Y, et al. Chem Biol. 2010 May 28;17(5):421-33. doi: 10.1016/j.chembiol.2010.04.012. Chem Biol. 2010. PMID: 20534341 Free PMC article. Review. - DNA topoisomerase-targeting chemotherapeutics: what's new?
Cuya SM, Bjornsti MA, van Waardenburg RCAM. Cuya SM, et al. Cancer Chemother Pharmacol. 2017 Jul;80(1):1-14. doi: 10.1007/s00280-017-3334-5. Epub 2017 May 20. Cancer Chemother Pharmacol. 2017. PMID: 28528358 Free PMC article. Review. - Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers.
Chen YL, Yang TY, Chen KC, Wu CL, Hsu SL, Hsueh CM. Chen YL, et al. Cell Oncol (Dordr). 2016 Oct;39(5):411-433. doi: 10.1007/s13402-016-0285-5. Epub 2016 Jun 15. Cell Oncol (Dordr). 2016. PMID: 27306525
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources